From the Editors

References

• Cunningham ET Jr, Zierhut M.SARS-CoV-2, COVID-19, and the Eye. Ocul Immunol Inflamm. May 19, 2021;29(4):629–630. doi:10.1080/09273948.2021.1970423.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr, Moorthy RS, Agarwal M, Smit DP, Zierhut M. Ocular complications following COVID-19 vaccination - coincidence, correlation, or causation? Ocul Immunol Inflamm. July, 2022;30(5):1031–1034. doi:10.1080/09273948.2022.2125763.
   PubMed Web of Science ®Google Scholar
• Ozdemir Yalcinsoy K, Ozdamar Erol Y, Ozdal PC. Bilateral granulomatous panuveitis in a patient with COVID-19. Ocul Immunol Inflamm. 2023;31(6): 1206–1209. doi:10.1080/09273948.2022.2061523.
   PubMed Web of Science ®Google Scholar
• Vienne-Jumeau A, Brézin AP, Debieb A. Bilateral anterior uveitis following paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 - case report and focused review. Ocul Immunol Inflamm. 2023;31(6): 1265–1269. doi:10.1080/09273948.2022.2143381.
   PubMed Web of Science ®Google Scholar
• Kılıçarslan O, Yılmaz Çebi A, Uçar D, Şentürk F, Aras C. Bilateral cystoid macular Edema after COVID-19: 1 year follow up. Ocul Immunol Inflamm. 2023;31(6): 1236–1239. doi:10.1080/09273948.2022.2114916.
   Web of Science ®Google Scholar
• Ayachit A, Joshi M, Ayachit G, Joshi S, Shah P-P-P-C. Presumed post-COVID infection retinitis - clinical and tomographic features of retinitis as a post-COVID syndrome. Ocul Immunol Inflamm. 2023;31(6): 1117–1121. doi:10.1080/09273948.2022.2060264.
   Web of Science ®Google Scholar
• Patnaik G, Arunkumar WV, Lagvankar M. Bilateral Acute Depigmentation of Iris (BADI) post COVID infection following systemic moxifloxacin therapy. Ocul Immunol Inflamm. 2023;31(6): 1210–1212. doi:10.1080/09273948.2022.2069126.
   PubMed Web of Science ®Google Scholar
• Altan C, Basarir B, Bayraktar S, Tugal-Tutkun I. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)following acute COVID-19 infection. Ocul Immunol Inflamm. 2023;31(6): 1163–1168. doi:10.1080/09273948.2022.2103832.
   Web of Science ®Google Scholar
• Niedzwiecka E, San Miguel MP C, Gonzalez Herrera M, Sánchez Rodriguez-Acosta I. Bilateral Acute Depigmentation of the Iris (BADI) following Covid-19 infection. Ocul Immunol Inflamm. 2023;31(6): 1230–1231. doi:10.1080/09273948.2022.2113801.
   Web of Science ®Google Scholar
• Tehrani S, Fekri S, Demirci H, et al. Coincidence of candida endophthalmitis, and aspergillus and Pneumocystis jirovecii pneumonia in a COVID-19 patient: case report. Ocul Immunol Inflamm. 2023;31(6): 1291–1294. doi:10.1080/09273948.2023.2188224.
   PubMed Web of Science ®Google Scholar
• Markan A, Dogra M, Katoch D, Tomar M, Mittal H, Singh R. Endogenous endophthalmitis in COVID-19 patients: a case series and literature review. Ocul Immunol Inflamm. 2023;31(6): 1191–1197. doi:10.1080/09273948.2023.2192273.
   Web of Science ®Google Scholar
• Manoharan A, Agarwal A, Dutta Majumder P. Acute retinal necrosis: a covid-19 perspective. Ocul Immunol Inflamm. 2023;31(6): 1270–1272. doi:10.1080/09273948.2022.2159842.
   Web of Science ®Google Scholar
• Shrivastav A, Zhou WS, Ng S, et al. Choroidal microvascular alterations in COVID-19 patients. Ocul Immunol Inflamm. 2023;31(6): 1122–1127. doi:10.1080/09273948.2022.2062387.
   Web of Science ®Google Scholar
• Nageeb Louz RE, Salah Eddin MA, Macky TA, Tolba DAA. Post COVID-19 retinal evaluation using optical coherence tomography angiography: a case control study. Ocul Immunol Inflamm. 2023;31(6): 1175–1183. doi:10.1080/09273948.2022.2141651.
   Web of Science ®Google Scholar
• Uzun S, Uzun F. Analysis of microvasculature in children recovered from COVID-19 using swept-source OCT/OCTA technology. Ocul Immunol Inflamm. 2023;31(6): 1310. doi:10.1080/09273948.2022.2094813.
   Web of Science ®Google Scholar
• Habot-Wilner Z, Neri P, Okada AA, et al. COVID vaccine-associated uveitis. Ocul Immunol Inflamm. 2023;31(6): 1198–1205. doi:10.1080/09273948.2023.2200858.
   Web of Science ®Google Scholar
• Ren J, Zhang T, Li X, Liu G. Ocular inflammatory reactions following an inactivated SARS-CoV-2 vaccine: a four case series. Ocul Immunol Inflamm. 2023;31(6): 1128–1133. doi:10.1080/09273948.2022.2093754.
   Web of Science ®Google Scholar
• Cho SK, Wu XN, Amaratunge C. Acute uveitis following AstraZeneca COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1295–1298. doi:10.1080/09273948.2023.2189456.
   PubMedGoogle Scholar
• Bellur S, Zeleny A, Patronas M, Jiramongkolchai K, Kodati S. Bilateral acute macular neuroretinopathy after COVID-19 vaccination and infection. Ocul Immunol Inflamm. 2023;31(6): 1222–1225. doi:10.1080/09273948.2022.2093753.
   PubMed Web of Science ®Google Scholar
• Bleicher ID, Brill D, Wu F, Sobrin L, Patel N. Acute idiopathic maculopathy following SARS-CoV-2 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1232–1235. doi:10.1080/09273948.2022.2114915.
   Web of Science ®Google Scholar
• Gargouri MA, Yousfi N, Toutain J, et al. Multiple evanescent white dot syndrome following COVID-19 mRNA vaccination. Ocul Immunol Inflamm. 2023;31(6): 1240–1244. doi:10.1080/09273948.2022.2127782.
   PubMed Web of Science ®Google Scholar
• Baharani A, Reddy RR. Multiple evanescent white dot syndrome following adenovirus vector-based COVID-19 vaccine (Covishield). Ocul Immunol Inflamm. 2023;31(6): 1299–1304. doi:10.1080/09273948.2023.2192271.
   Web of Science ®Google Scholar
• Shen C, Tennant M. Unilateral acute idiopathic blind spot enlargement following second dose of Covid-19 mRNA vaccine. Ocul Immunol Inflamm. 2023;31(6): 1219–1221. doi:10.1080/09273948.2022.2090964.
   Web of Science ®Google Scholar
• Chean CS, Ali E, Kulkarni P, Kapoor B, Kumar P. Bilateral persistent placoid maculopathy following COVID-19 vaccines: real or coincidence? Ocul Immunol Inflamm. 2023;31(6): 1273–1278. doi:10.1080/09273948.2023.2170889.
   PubMed Web of Science ®Google Scholar
• Yi Z, Chen L, Zheng H, Chen C. Retinal vasculitis following COVID-19 vaccination: causation or coincidence? Ocul Immunol Inflamm. 2023;31(6): 1283–1285. doi:10.1080/09273948.2023.2176887.
   PubMed Web of Science ®Google Scholar
• Mohamed S, Chan CK, Tsang CW, et al. Case report: retinal vasculitis in two adolescents after COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1245–1249. doi:10.1080/09273948.2022.2129694.
   Web of Science ®Google Scholar
• Chandrasekaran PR. A curious case of occlusive retinal vasculitis in a young individual associated with COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1254–1260. doi:10.1080/09273948.2022.2137046.
   Web of Science ®Google Scholar
• Takacs A, Ecsedy M, Nagy ZZ. Possible COVID-19 MRNA vaccine-induced case of unilateral central retinal vein occlusion. Ocul Immunol Inflamm. 2023;31(6): 1145–1150. doi:10.1080/09273948.2022.2094811.
   Web of Science ®Google Scholar
• Shah PP, Glidai Y, Braunstein R, et al. Reports of new and recurrent keratitis following mRNA-based COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1169–1174. doi:10.1080/09273948.2022.2133730.
   Web of Science ®Google Scholar
• Cohen S, Olshaker H, Fischer N, et al. Herpetic Eye disease following the SARS-CoV-2 vaccinations. Ocul Immunol Inflamm. 2023;31(6): 1151–1162. doi:10.1080/09273948.2022.2103831.
   Web of Science ®Google Scholar
• Marziali E, Pasqualetti R, Bacci G, de Libero C, Caputo R. Acute rejection following COVID-19 vaccination in penetrating keratoplasty in a Young Male - a case report and review of literature. Ocul Immunol Inflamm. 2023;31(6): 1226–1229. doi:10.1080/09273948.2022.2106248.
   Web of Science ®Google Scholar
• Sanjay S, Handa A, Kawali A, Shetty R, Bhakti Mishra S, Mahendradas P. Scleritis and episcleritis following coronavirus disease (COVID-19) vaccination. Ocul Immunol Inflamm. 2023;31(6): 1184–1190. doi:10.1080/09273948.2023.2182324.
   Web of Science ®Google Scholar
• de Queiroz Tavares Ferreira F, Araújo DC, de Albuquerque LM, Bianchini PM, Holanda EC, Pugliesi A. Possible association between Vogt-Koyanagi-Harada disease and coronavirus disease vaccine: a report of four cases. Ocul Immunol Inflamm. 2023;31(6): 1134–1140. doi:10.1080/09273948.2022.2093756.
   Web of Science ®Google Scholar
• Shirah B, Mulla I, Aladdin Y. Optic neuritis following the BNT162b2 mRNA COVID-19 vaccine in a patient with systemic lupus erythematosus uncovering the diagnosis of neuromyelitis optica spectrum disorders. Ocul Immunol Inflamm. 2023;31(6): 1213–1215. doi:10.1080/09273948.2022.2089901.
   Web of Science ®Google Scholar
• Saluja P, Kohli GM, More A, Shetty SB, Sen A. Bilateral atypical optic neuritis following ChAdOx1_nCoV-19 vaccination: a putative plausibility. Ocul Immunol Inflamm. 2023;31(6):1250–1253. doi:10.1080/09273948.2022.2137044.
   Web of Science ®Google Scholar
• Yoshida N, Tsukada A. A case of neuroretinitis following COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1261–1264. doi:10.1080/09273948.2022.2137047.
   Google Scholar
• Nair GS, Khan IA, Rizvi SWA, Shahid S. A case of neuroretinitis following inactivated virion COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1279–1282. doi:10.1080/09273948.2023.2173244.
   Google Scholar
• Hung CW, Hung CH. Reactivation of graves’ disease and thyroid Eye disease following COVID-19 vaccination - a case report. Ocul Immunol Inflamm. 2023;31(6): 1286–1290. doi:10.1080/09273948.2023.2176889.
   Google Scholar
• Yucel Gencoglu A, Mangan MS. Orbital inflammatory pseudotumor following mRNA COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1141–1144. doi:10.1080/09273948.2022.2093757.
   Google Scholar